Welcome, Guest. Please login or register.
April 16, 2024, 05:05:11 pm

Login with username, password and session length


Members
  • Total Members: 37635
  • Latest: Ranoye
Stats
  • Total Posts: 773156
  • Total Topics: 66328
  • Online Today: 248
  • Online Ever: 5484
  • (June 18, 2021, 11:15:29 pm)
Users Online
Users: 2
Guests: 198
Total: 200

Welcome


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Do I Have HIV?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: alpha-defensins -1, -2, and -3 what is status of this breakthrough?  (Read 4556 times)

0 Members and 1 Guest are viewing this topic.

Offline bimazek

  • Member
  • Posts: 781
Tuesday, 30 January 2007
Protein-packed HIV breakthrough raises hope
ID   20021005
By   Sapa-AFP,
Summary   Washington - American and Chinese researchers have announced that they have identified a group of proteins that naturally block HIV from developing into Aids, a discovery that could revolutionise HIV treatment.

A team of US and Chinese scientists at the Aaron Diamond AIDS Research Centre (ADARC) in New York succeeded in identifying the proteins, alpha-defensins -1, -2, and -3, found in a small percentage of HIV-positive people known as long-term non-progressors.

This group, who account for one to two percent of all HIV-positive people in the US, live with HIV without developing Aids.

The discovery, the details of which are to published in Friday's edition of Science magazine, follows a lead that was discovered in 1986.

Scientists then discovered that the human body's CD8 T cells produced some unidentifiable factors that inhibited HIV replication.

Then, in 1995, researchers found a family of proteins called beta-chemokines that accounted for some of the HIV suppression, but were not effective against all the strains of the virus.
The ADARC team compared the CD8 T cells in long-term non-progressors with the same cells in HIV patients whose immune systems had failed.

They found alpha-defensins -1, -2, and -3 in people who stayed healthy and a lack of these proteins in those whose immune systems had failed. The proteins suppressed all strands of HIV.

To confirm that these three proteins were responsible for controlling the virus, the team artificially stripped the alpha-defensins from the proteins produced by CD8 T cells taken from long-term non-progressors and found that their HIV-blocking capabilities had been virtually eliminated.

To better judge the potency of the alpha-defensins, researchers compared synthesised versions of the proteins made in laboratories with a purified version derived from human cells.

The natural form was at least 10 to 20 times stronger than the synthetic version. ADARC researchers are working to improve the potency of the synthetic form. (Source: Sapa-AFP, September 26 2002)
Story   

Washington - American and Chinese researchers have announced that they have identified a group of proteins that naturally block HIV from developing into Aids, a discovery that could revolutionise
HIV treatment.

A team of US and Chinese scientists at the Aaron Diamond AIDS Research Centre (ADARC) in New York succeeded in identifying the proteins, alpha-defensins -1, -2, and -3, found in a small percentage of HIV-positive people known as long-term
non-progressors.

This group, who account for one to two percent of all HIV-positive people in the US, live with HIV without developing
AIDS.

"This discovery is a major step forward in our understanding of how the body fights HIV," said Linqi Zhang, head of the team. "By understanding how some people's immune systems control HIV infection, we may be able to develop new treatments that take advantage of this phenomenon."

The discovery, the details of which are to published in Friday's edition of Science magazine, follows a lead that was discovered in 1986.

Scientists then discovered that the human body's CD8 T cells produced some unidentifiable factors that inhibited HIV replication.

Then, in 1995, researchers found a family of proteins called beta-chemokines that accounted for some of the HIV suppression, but were not effective against all the strains of the virus.

The ADARC team compared the CD8 T cells in long-term non-progressors with the same cells in HIV patients whose immune systems had failed.

They found alpha-defensins -1, -2, and -3 in people who stayed healthy and a lack of these proteins in those whose immune systems had failed. The proteins suppressed all strands of HIV.

To confirm that these three proteins were responsible for controlling the virus, the team artificially stripped the alpha-defensins from the proteins produced by CD8 T cells taken from long-term non-progressors and found that their HIV-blocking capabilities had been virtually eliminated.

To better judge the potency of the alpha-defensins, researchers compared synthesised versions of the proteins made in laboratories with a purified version derived from human cells.

The natural form was at least 10 to 20 times stronger than the synthetic version.
ADARC researchers are working to improve the potency of the synthetic form.
(Source: Sapa-AFP,  September 26 2002)

Offline Optimistic

  • Member
  • Posts: 326
  • An Apple A Day Keeps The Doctors Away!
Re: alpha-defensins -1, -2, and -3 what is status of this breakthrough?
« Reply #1 on: January 30, 2007, 01:12:06 pm »
I don't know the status of this breakthrough, but this is certainly excellent news.  Let's hope something promsing will come out of this study.

Justin
12/06 (Atripla): cd4 - 260; cd% - 33%; vl - 169
1/07 (Atripla): cd4 - 267; cd% - 38.1%; vl - 132
4/07 (Atripla): cd4 - 373; cd% - 33.9%; vl - <50
7/07 (Atripla); cd4 - 287; cd% - 35.8%; vl - <50
9/07 (Atripla); cd4 - 356; cd% - 39.5%; vl - <50
12/07 (Atripla); cd4 - 517

 


Terms of Membership for these forums
 

© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.